Intellipharmaceutics International Inc. Annual Net Income (Loss) Attributable to Parent in CAD from 2014 to 2018

Taxonomy & unit
us-gaap: CAD and USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Intellipharmaceutics International Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from 2014 to 2018.
  • Intellipharmaceutics International Inc. Net Income (Loss) Attributable to Parent for the quarter ending May 31, 2017 was -CA$1.81M, a 9.74% increase year-over-year.
  • Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2018 was -CA$13.7M, a 55.2% decline from 2017.
  • Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2017 was -CA$8.86M, a 12.7% increase from 2016.
  • Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2016 was -CA$10.1M, a 36.4% decline from 2015.
Net Income (Loss) Attributable to Parent, Annual (CAD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2018 -13.7M -4.89M -55.2% Dec 1, 2017 Nov 30, 2018 20-F/A 2019-03-04
2017 -8.86M +1.29M +12.7% Dec 1, 2016 Nov 30, 2017 20-F/A 2019-03-04
2016 -10.1M -2.71M -36.4% Dec 1, 2015 Nov 30, 2016 20-F/A 2019-03-04
2015 -7.44M -3.58M -92.8% Dec 1, 2014 Nov 30, 2015 20-F 2018-03-01
2014 -3.86M Dec 1, 2013 Nov 30, 2014 20-F 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.